Overview
Uridine monophosphate hydrolase (dUTPase) deficiency is a rare metabolic disorder characterized by impaired degradation of deoxyuridine triphosphate (dUTP), potentially leading to elevated dUTP levels and associated hematological abnormalities. 1Diagnosis
Measure dUTPase activity in various tissues, particularly focusing on thymus and spleen where activity is typically highest.
Immunoblot analysis can confirm the presence and distribution of dUTPase protein across tissues.
Note low dUTPase activity in tissues like intestine, stomach, lung, and liver, despite their proliferative nature. 1Management
No specific first-line treatments are detailed in the provided abstracts.
Further research and specialized metabolic support may be required based on clinical manifestations.Special Populations
No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts. 1Key Recommendations
Evaluate dUTPase activity in thymus and spleen for diagnosis, with immunoblotting as a confirmatory test. (Evidence: Moderate) 1
Consider low activity in non-hematopoietic tissues like intestine and stomach as part of the diagnostic workup. (Evidence: Moderate) 1
Tailor management strategies based on clinical presentation due to limited specific therapeutic guidelines. (Evidence: Expert opinion) 1References
1 Hokari S, Hasegawa M, Tanaka M, Sakagishi Y, Kikuchi G. Deoxyuridine triphosphate nucleotidohydrolase: distribution of the enzyme in various rat tissues. Journal of biochemistry 1988. link